	Effectiveness of a Health Awareness Program for Early Detection of Breast Cancer Among Female Patient Attendants in a Selected Hospital in North-East India: A Preexperimental Pretest-Posttest Study. Cureus Devi MB, Sharma JD, Baruah MK, Kashyap K, Saikia K, Mahanta P Sr. PMID: 41835635 [PubMed - as supplied by publisher]
	A phase II randomized placebo-controlled study of fisetin to improve physical function in breast cancer survivors: the TROFFi study rationale and trial design. Ther Adv Med Oncol Ji J, Crespi CM, Yee L, Zekster YA, Al-Saleem A, Petersen L, Lee C, Son N, Smith C, Evans T, Tchkonia T, Kirkland JL, Kuchel GA, Cohen HJ, Sedrak MS. PMID: 41835341 [PubMed - as supplied by publisher]
	Real-world outcomes of trastuzumab deruxtecan in patients with HER2+ metastatic breast cancer: Turkish oncology group multicenter study. Ther Adv Med Oncol Sahin TK, Kemik F, Muglu H, Acikgöz Yildiz B, Biter S, Tunbekici S, Oruc A, Guren AK, Kaban K, Guzel HG, Erol C, Aykan MB, Koylu B, Ekinci OB, Deliktas Onur I, Kalem A, Altunok O, Seyyar M, Guney B, Akdogan O, Ismayilov R, Ardic FS, Yazici M, Majidova N, Turker S, Esin E, Cabuk D, Yasar HA, Oguz A, Yazici O, Gursu RU, Y, Yesil Cinkir H, Ates O, Celik E, Karadurmus N, Demirci U, Ozturk B, Mandel NM, Bayoglu IV, Araz M, Goker E, Bayram E, Erdem D, Selcukbiricik F, Basaran G, Sezer A, Dogu GG, Kemal Y, Bilici A, Gunduz S, Guven DC, Aksoy S. PMID: 41835339 [PubMed - as supplied by publisher]
	Emerging roles of haemostatic proteins as markers of disease progression and prognosis in breast cancer. Explor Target Antitumor Ther Izuegbuna OO. PMID: 41835213 [PubMed - as supplied by publisher]
	Purinergic Signaling in Ovarian Carcinoma. Adv Pharm Bull Martínez-Ramírez AS, Nuñez-Ríos JD, Juárez-Mercado AP, Campos-Contreras ADR, Vázquez-Cuevas FG. PMID: 41835052 [PubMed - as supplied by publisher]
	A Nonrandomized Clinical Trial Investigating Keratinocyte Growth Factor-Hair Serum for the Prevention of Chemotherapy-Induced Alopecia. J Cosmet Dermatol Mann K, Potluri P, Paul EE, Segar JM, Ehsani S, Roe D, Chalasani P. PMID: 41834767 [PubMed - indexed for MEDLINE]
	Risk Factors for Recurrence and Complications Following Cytoreductive Surgery in Platinum-Resistant Ovarian Cancer: A Retrospective Cohort Study. Ann Ital Chir Wang L, Yao L, Wan J, Xiao Z. PMID: 41834542 [PubMed - indexed for MEDLINE]
	Exploring the Relationship Between MDM4 Gene Polymorphisms (rs1380576 and rs4245739) and Breast Cancer Susceptibility in Bangladesh: A Case-Control Study. J Clin Lab Anal Islam JMA, Ahamed S, Islam S, Hossain MM, Hossain MS, Mostaid MS, Islam MR, Haque MA. PMID: 41834461 [PubMed - as supplied by publisher]
	Comprehensive assessment of incidence, mortality, and lifetime risk of ovarian cancer: a global study with forecasts to 2050. J Gynecol Oncol Jiang Y, Xu Q, Liu Y. PMID: 41834412 [PubMed - as supplied by publisher]
	Synchronous Presentation of Gastric-Type Adenocarcinoma InÂ Situ of Cervix and Vagina in a Young Adult Female: A Precursor Seldom Seen. J Obstet Gynaecol Res Halder S, Singh S, Sood R, Mathur S, Manchanda S, Malhotra N, Singhal S. PMID: 41834193 [PubMed - indexed for MEDLINE]
	OPTIMAL: A Multinational Phase III Study of Oral Paclitaxel (DHP107) versus Intravenous Weekly Paclitaxel in HER2-Negative Recurrent or Metastatic Breast Cancer. Ann Oncol Xu B, Jeong H, Sun T, Sohn J, Zhang Q, Kostic S, Wang X, Tong Z, Wang S, Wang J, Li W, Lee KS, Moon YW, Kang MJ, Hu X, Kim TY, Milenkovi, Seo JH, Kim JH, Lee J, Kim SB. PMID: 41833903 [PubMed - as supplied by publisher]
	Homologous recombination deficiency in Ovarian Cancer: The Game-Changer for First-Line Maintenance Therapy. Crit Rev Oncol Hematol Cannizzaro MC, Minucci A, Zormpas-Petridis K, Ghizzoni V, Fagotti A, Lorusso D, Salutari V, Nero C. PMID: 41833892 [PubMed - as supplied by publisher]
	PD-L1 Testing in Triple-Negative Breast Cancer: National Practice and Interlaboratory Variation in the Netherlands. Lab Invest Dekker M, Hempenius MA, de Bock GH, van Kruchten M, van Vugt MATM, Siebers AG, van der Vegt B. PMID: 41833641 [PubMed - as supplied by publisher]
	Study on the Mechanism of Post-Chemotherapy Metastasis in Breast Cancer Based on Metabolomics and Development of TCM Metabolic Regulators. Anticancer Agents Med Chem Yu Z, Wang W, Tao J, Qiu Y, Wang M, Qiu Z, Zhu W. PMID: 41833028 [PubMed - as supplied by publisher]
	Comparative Prognosis of HER2-Low versus HER2-Negative Breast Cancer: A Meta-Analysis. Anticancer Agents Med Chem Li Y, Chen T, Tang C, Cui H, Li C. PMID: 41833026 [PubMed - as supplied by publisher]
	Long-Term follow-up of S0221, comparing alternative Dose-Schedules of anthracycline/taxane therapy in early breast cancer. JNCI Cancer Spectr Ali A, Barlow WE, Moore HCF, Hobday TJ, Isaacs C, Salim M, Albain KS, Chew HK, Burton GV, Srkalovic G, McGregor BA, Flaherty LE, Lew DL, Gralow JR, Hortobagyi GN, Sharma P, Pusztai L, Budd GT. PMID: 41832961 [PubMed - as supplied by publisher]
	Clinical and sociodemographic characteristics associated with health-related quality of life among older breast cancer survivors. Womens Health (Lond) Schneider J, Wojcik KM, Tian E, Wilson OWA, Jayasekera J. PMID: 41832777 [PubMed - indexed for MEDLINE]
	Exploring risk factors and survival rates in invasive cervical carcinoma: New perspectives. Tunis Med Belhadj A, Boumeddane YK, Meddah D, Sahraoui T. PMID: 41832650 [PubMed - indexed for MEDLINE]
	Application and prospect of breast cancer organoids model in the field of traditional Chinese medicine and natural compounds. J Transl Med Liang H, Sun X, Shi G, Chen H, Li J. PMID: 41832573 [PubMed - as supplied by publisher]
	Association of MET gene polymorphisms with breast cancer risk in Nigerian patients: a case-control study. BMC Cancer Amuji DN, Iweala EEJ. PMID: 41832464 [PubMed - as supplied by publisher]

Articles 1 - 20 / 325962

Page 1 of 16299



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy